Literature DB >> 11037624

The role of protein kinase C in the development of the complications of diabetes.

D K Ways1, M J Sheetz.   

Abstract

Diabetes mellitus produces a state of chronic hyperglycemia which in turn leads to the development of severe complications including retinopathy, nephropathy, neuropathy, and atherosclerosis. Many different mechanisms have been put forward to attempt to explain how glucose elevations can damage these various organ systems. Protein kinase C activation is one of the sequelae of hyperglycemia and is thought to play a role in the development of diabetic complications. There are multiple mechanisms for its activation in the diabetic state and multiple downstream effects attributable to that activation. The role of protein kinase C activation in the development of the above-mentioned complications of diabetes is discussed in this chapter. In addition, the potential use of isoform-specific inhibitors of protein kinase C for the treatment of diabetic complications is proposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037624     DOI: 10.1016/s0083-6729(00)60019-5

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  10 in total

1.  Differential recruitment of PKC isoforms in HeLa cells during redox stress.

Authors:  Alessandro Rimessi; Rosario Rizzuto; Paolo Pinton
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

2.  Characterization of hearing loss in aged type II diabetics.

Authors:  Susan T Frisina; Frances Mapes; SungHee Kim; D Robert Frisina; Robert D Frisina
Journal:  Hear Res       Date:  2005-11-23       Impact factor: 3.208

Review 3.  Effect of systemic medications on onset and progression of diabetic retinopathy.

Authors:  Paolo S Silva; Jerry D Cavallerano; Jennifer K Sun; Lloyd M Aiello; Lloyd Paul Aiello
Journal:  Nat Rev Endocrinol       Date:  2010-07-27       Impact factor: 43.330

Review 4.  Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE.

Authors:  Domenico Merante; Francesca Menchini; Kenneth E Truitt; Francesco M Bandello
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

5.  Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus.

Authors:  Yong Ding; Alpdogan Kantarci; John A Badwey; Hatice Hasturk; Alan Malabanan; Thomas E Van Dyke
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

6.  Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats.

Authors:  Rie Ishizawa; Han-Kyul Kim; Norio Hotta; Gary A Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith; Masaki Mizuno
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

7.  A Radioactive-free Kinase Inhibitor Discovery Assay Against the Trypanosoma brucei Glycogen Synthase Kinase-3 short (TbGSK-3s).

Authors:  Antonia Efstathiou; Despina Smirlis
Journal:  Bio Protoc       Date:  2020-01-20

8.  Prevention of diabetic eye disease: the commonest cause of blindness in individuals younger than 65 years.

Authors:  Patrizio Tatti; Patrizia Di Mauro; Leonardo Masselli; Adriano Longobardi; Annabel Barber
Journal:  Clin Ophthalmol       Date:  2010-11-15

9.  Identification of Key LncRNAs and Pathways in Prediabetes and Type 2 Diabetes Mellitus for Hypertriglyceridemia Patients Based on Weighted Gene Co-Expression Network Analysis.

Authors:  Shoumeng Yan; Mengzi Sun; Lichao Gao; Nan Yao; Tianyu Feng; Yixue Yang; Xiaotong Li; Wenyu Hu; Weiwei Cui; Bo Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

10.  Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.

Authors:  Chi-Juei Jeng; Yi-Ting Hsieh; Chung-May Yang; Chang-Hao Yang; Cheng-Li Lin; I-Jong Wang
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.